Aga2 (abnormal gait 2) mouse model, with a dominant frameshift mutation in Col1a1 C-propeptide, is broadly applicable, especially for non-skeletal aspects of dominant OI such as cardiovascular and respiratory defects as well as apoptosis studies [22, 23]. This evidence concerns the gene COL1A1 and osteogenesis imperfecta.